TytoCare Names Adam Pellegrini Chief

TytoCare announced a leadership change on July 15, 2026. TytoCare named Adam Pellegrini Chief Executive Officer alongside a $25 million-plus growth round led by Insight Partners to scale its AI-first clinical enablement platform.

What changed

Adam Pellegrini was named Chief Executive Officer.

Leader: Adam Pellegrini
Role: Chief Executive Officer
Effective: Not specified in the announcement
Announcement date: July 15, 2026

Leadership background

Pellegrini brings more than two decades of experience at the intersection of digital health, consumer health technology, and large-scale clinical programs, the company said. The announcement did not name his prior employers or titles.

The mandate

TytoCare said that under Pellegrini it will pursue a clinical enablement model that embeds its AI-assisted examination capabilities into the care workflows of health systems, specialty programs, and payer-sponsored chronic disease management platforms. The company said the new financing will support expanding its AI clinical algorithms pipeline, deepening payer and health system partnerships, and accelerating go-to-market efforts.

Why this matters for GTM teams

Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.

Source and methodology

This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.

Primary source: TytoCare leadership announcement.